Adagio Therapeutics Inc.

NASDAQ: ADGI · Real-Time Price · USD
4.64
0.04 (0.87%)
At close: Sep 13, 2022, 6:00 AM

Adagio Therapeutics Revenue

Adagio Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2022, Adagio Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
101
Market Cap
505.68M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2021 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.